These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 29188576)

  • 41. Molecular Basis of Ligand Dissociation from G Protein-Coupled Receptors and Predicting Residence Time.
    Guo D; IJzerman AP
    Methods Mol Biol; 2018; 1705():197-206. PubMed ID: 29188564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure-Based Virtual Screening.
    Li Q; Shah S
    Methods Mol Biol; 2017; 1558():111-124. PubMed ID: 28150235
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Probing the orphan receptors: Tools and directions.
    Franchini L; Orlandi C
    Prog Mol Biol Transl Sci; 2023; 195():47-76. PubMed ID: 36707155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fragment-based lead discovery on G-protein-coupled receptors.
    Visegrády A; Keserű GM
    Expert Opin Drug Discov; 2013 Jul; 8(7):811-20. PubMed ID: 23621346
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Class A GPCRs: Structure, Function, Modeling and Structure-based Ligand Design.
    Cong X; Topin J; Golebiowski J
    Curr Pharm Des; 2017 Nov; 23(29):4390-4409. PubMed ID: 28699533
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Machine Learning Approach for the Discovery of Ligand-Specific Functional Mechanisms of GPCRs.
    Plante A; Shore DM; Morra G; Khelashvili G; Weinstein H
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31159491
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure-based molecular modeling approaches to GPCR oligomerization.
    Kaczor AA; Selent J; Poso A
    Methods Cell Biol; 2013; 117():91-104. PubMed ID: 24143973
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Do crystal structures obviate the need for theoretical models of GPCRs for structure-based virtual screening?
    Tang H; Wang XS; Hsieh JH; Tropsha A
    Proteins; 2012 Jun; 80(6):1503-21. PubMed ID: 22275072
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Constitutively active BRS3 is a genuinely orphan GPCR in placental mammals.
    Tang H; Shu C; Chen H; Zhang X; Zang Z; Deng C
    PLoS Biol; 2019 Mar; 17(3):e3000175. PubMed ID: 30840614
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Approaches for Differentiation and Interconverting GPCR Agonists and Antagonists.
    Miszta P; Jakowiecki J; Rutkowska E; Turant M; Latek D; Filipek S
    Methods Mol Biol; 2018; 1705():265-296. PubMed ID: 29188567
    [TBL] [Abstract][Full Text] [Related]  

  • 51. GPCR profiling: from hits to leads and from genotype to phenotype.
    Cvijic ME; Sum CS; Alt A; Zhang L
    Drug Discov Today Technol; 2015 Nov; 18():30-7. PubMed ID: 26723890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Application of Multiscale Simulation Tools on GPCRs. An Example with Angiotensin II Type 1 Receptor.
    Erol I; Aksoydan B; Kantarcioglu I; Durdagi S
    Methods Mol Biol; 2018; 1824():431-448. PubMed ID: 30039423
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Importance of protein dynamics in the structure-based drug discovery of class A G protein-coupled receptors (GPCRs).
    Lee Y; Lazim R; Macalino SJY; Choi S
    Curr Opin Struct Biol; 2019 Apr; 55():147-153. PubMed ID: 31102980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Docking and Virtual Screening Strategies for GPCR Drug Discovery.
    Beuming T; Lenselink B; Pala D; McRobb F; Repasky M; Sherman W
    Methods Mol Biol; 2015; 1335():251-76. PubMed ID: 26260606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PyPLIF HIPPOS-Assisted Prediction of Molecular Determinants of Ligand Binding to Receptors.
    Istyastono EP; Yuniarti N; Prasasty VD; Mungkasi S
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33922338
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Do orphan G-protein-coupled receptors have ligand-independent functions? New insights from receptor heterodimers.
    Levoye A; Dam J; Ayoub MA; Guillaume JL; Jockers R
    EMBO Rep; 2006 Nov; 7(11):1094-8. PubMed ID: 17077864
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery of nanomolar ligands with novel scaffolds for the histamine H4 receptor by virtual screening.
    Levoin N; Labeeuw O; Billot X; Calmels T; Danvy D; Krief S; Berrebi-Bertrand I; Lecomte JM; Schwartz JC; Capet M
    Eur J Med Chem; 2017 Jan; 125():565-572. PubMed ID: 27718472
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Homology model-assisted elucidation of binding sites in GPCRs.
    Levit A; Barak D; Behrens M; Meyerhof W; Niv MY
    Methods Mol Biol; 2012; 914():179-205. PubMed ID: 22976029
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Benchmarking GPCR homology model template selection in combination with de novo loop generation.
    Szwabowski GL; Castleman PN; Sears CK; Wink LH; Cole JA; Baker DL; Parrill AL
    J Comput Aided Mol Des; 2020 Oct; 34(10):1027-1044. PubMed ID: 32737667
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protein-Protein Docking in Drug Design and Discovery.
    Kaczor AA; Bartuzi D; Stępniewski TM; Matosiuk D; Selent J
    Methods Mol Biol; 2018; 1762():285-305. PubMed ID: 29594778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.